BiomX PHGE
NYSE PHGE
$0.14 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

BiomX (PHGE) Total Non-Current Liabilities (2018 - 2026)

BiomX (PHGE) posted Total Non-Current Liabilities of $1.7 million for Q1 2026, up 138.67% sequentially from $706000.0 in Q4 2025, and down 88.08% YoY from $14.1 million in Q1 2025.

BiomX (PHGE) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends

BiomX has reported Total Non-Current Liabilities for 9 years, with the latest figure at $1.7 million in Q1 2026.

  • Quarterly Total Non-Current Liabilities fell 88.08% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (down 88.08% YoY) and the FY2025 annual result came in at $706000.0, down 93.47% from the prior year.
  • Total Non-Current Liabilities grew to $1.7 million in Q1 2026 per PHGE's latest filing, from $706000.0 in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $33.9 million in Q2 2024 and troughed at $706000.0 in Q4 2025.
  • A 5-year average of $13.8 million and a median of $13.4 million in 2023 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities soared 261.51% in 2022, then sank 93.47% in 2025.
  • Over 5 years, Total Non-Current Liabilities stood at $16.6 million in 2022, then sank by 34.92% to $10.8 million in 2023, then gained by 0.43% to $10.8 million in 2024, then tumbled by 93.47% to $706000.0 in 2025, then jumped by 138.67% to $1.7 million in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $1.7 million, $706000.0, and $10.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 5.92 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 7.74 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 40.00 Mn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 3.92 Bn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 1.88 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 4.20 Bn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 1.17 Bn
8 Royalty Pharma 26.98 Bn 26.14 Bn - 9.32 Bn
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 724.15 Mn
10 BiomX 361,408.40 -806,591.60 - 1.69 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.69 Mn
Dec 31, 2025 706,000.00
Sep 30, 2025 10.46 Mn
Jun 30, 2025 12.63 Mn
Mar 31, 2025 14.13 Mn
Dec 31, 2024 10.82 Mn
Sep 30, 2024 13.14 Mn
Jun 30, 2024 33.89 Mn
Dec 31, 2023 10.77 Mn
Sep 30, 2023 12.12 Mn
Jun 30, 2023 13.72 Mn
Mar 31, 2023 15.06 Mn
Dec 31, 2022 16.55 Mn
Sep 30, 2022 17.86 Mn
Jun 30, 2022 19.15 Mn
Mar 31, 2022 18.88 Mn
Dec 31, 2021 19.41 Mn
Sep 30, 2021 19.37 Mn
Jun 30, 2021 5.30 Mn
Mar 31, 2021 5.31 Mn